Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/18/16 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 03/18/16 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 03/18/16 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 03/18/16 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 03/18/16 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 03/18/16 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 03/18/16 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 03/17/16 | Current report filing |
|
13 | ||
| 03/16/16 | Current report filing |
|
46 | ||
| 03/15/16 | Prospectus filed pursuant to Rule 424(b)(5) |
|
69 |